Spanish pharma company Rovi has said the potential contamination of some doses of the coronavirus vaccine which it manufactures for Moderna was under investigation and appeared limited to some batches for Japan.

A spokesperson for the Madrid-listed company, which handles the final fill-and-finish stage for customers outside of the United States, said production had not been halted at its plants.